Form 4: Haemonetics EVP, Chief Financial Officer James D'Arecca Reports Stock Disposals for Tax Obligations
SEC Form 4 Filing
James D'Arecca, EVP and Chief Financial Officer of Haemonetics, reported disposing of shares to cover tax obligations related to vesting restricted stock units.
Summary
- James D'Arecca, the EVP and Chief Financial Officer of Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2024, 412 shares of common stock were disposed of at a price of $96.49 to cover tax obligations.
- On May 16, 2024, 351 shares of common stock were disposed of at a price of $94.8 to cover tax obligations.
- Following these transactions, D'Arecca beneficially owns 12,907 shares of Haemonetics Corp, which includes unvested RSUs.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock disposals for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals to cover tax obligations are common when restricted stock units vest.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | 412 shares of common stock disposed of at $96.49 for tax obligations. |
| 05/16/2024 | 351 shares of common stock disposed of at $94.8 for tax obligations. |
| 05/17/2024 | Date of signature by attorney-in-fact for Mr. D'Arecca. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.